ProSolv introduces next-generation cardiovascular app
ProSolv CardioVascular, a FujiFilm company, has released its ProSolv CardioVascular 4.0, a web-based application for full viewing and reporting capabilities using web communication protocols, secured via SSL. The application can be downloaded and installed via a web URL.
Other enhancements to the software include new clinical tools to further aid the diagnostic process, and the integration to Fujifilm Medical Systems’ Synapse PACS, according to the Indianapolis-based ProSolv.
The company said that new clinical reporting features include pediatric echo reporting and a z-score module, so users can report more than 40 pediatric measurements and calculations against the normal ranges and z-scores. For nuclear cardiology, Invia 4DM-SPECT version 5.2 is now supported, offering features like saved state. Other new enhancements introduced include a new default echo measurement analysis package, updates to coronary tree functionality and resting ECG management, including Holter monitoring support delivered by the application’s OpenECG Module, powered by Epiphany.
ProSolv CardioVascular 4.0 is immediately being rolled out across the United States.
Other enhancements to the software include new clinical tools to further aid the diagnostic process, and the integration to Fujifilm Medical Systems’ Synapse PACS, according to the Indianapolis-based ProSolv.
The company said that new clinical reporting features include pediatric echo reporting and a z-score module, so users can report more than 40 pediatric measurements and calculations against the normal ranges and z-scores. For nuclear cardiology, Invia 4DM-SPECT version 5.2 is now supported, offering features like saved state. Other new enhancements introduced include a new default echo measurement analysis package, updates to coronary tree functionality and resting ECG management, including Holter monitoring support delivered by the application’s OpenECG Module, powered by Epiphany.
ProSolv CardioVascular 4.0 is immediately being rolled out across the United States.